MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 121 filers reported holding MYOVANT SCIENCES LTD in Q4 2022. The put-call ratio across all filers is 1.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $75,455 | +50.9% | 2,799 | +0.8% | 0.00% | – |
| Q3 2022 | $50,000 | +42.9% | 2,778 | -1.2% | 0.00% | – |
| Q2 2022 | $35,000 | -5.4% | 2,811 | +0.7% | 0.00% | – |
| Q1 2022 | $37,000 | -80.0% | 2,791 | -76.4% | 0.00% | – |
| Q4 2021 | $185,000 | -74.1% | 11,849 | -62.7% | 0.00% | – |
| Q3 2021 | $714,000 | -71.6% | 31,801 | -71.2% | 0.00% | – |
| Q2 2021 | $2,517,000 | -38.0% | 110,554 | -43.9% | 0.00% | – |
| Q1 2021 | $4,057,000 | -37.5% | 197,177 | -16.1% | 0.00% | -100.0% |
| Q4 2020 | $6,489,000 | -70.6% | 234,935 | -85.0% | 0.00% | -50.0% |
| Q3 2020 | $22,041,000 | -62.9% | 1,568,769 | -45.6% | 0.00% | -71.4% |
| Q2 2020 | $59,409,000 | +1103.1% | 2,881,140 | +340.5% | 0.01% | +600.0% |
| Q1 2020 | $4,938,000 | -51.3% | 654,006 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $10,150,000 | – | 654,006 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
| Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
| VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
| Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
| Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
| Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
| Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
| Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
| Matisse Capital | 32,750 | $508,000 | 0.36% |
| VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |